LLY
ELI LILLY & Co
Compliant- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Score
- 97/100
- Data as of
- 2026-02-12
How is this score computed?
The score has two parts. The verdict sets the base — Compliant starts at 50. Then up to 50 more is added for headroom: the further a company's ratios sit below their limits, the higher it climbs. Barely clearing the limits lands near 50; plenty of room to spare approaches 100.
LLY's ratios average 93.92% of headroom below their limits, so it scores 97 (50 base + 47 for headroom).
Price
Screening standard
How the verdict was computed
- Business activity
Business activity is compliant.
- Debt vs. market cap3.39% vs limit 33.00%
interest-bearing debt / market cap = 3.39% (< 33% limit).
- Interest income vs. revenue0.27% vs limit 5.00%
interest income / total revenue = 0.27% (< 5% limit).
- Cash & interest-bearing assets vs. market cap0.85% vs limit 33.00%
(cash + interest-bearing securities) / market cap = 0.85% (< 33% limit).
Every number, sourced
Figures read directly from SEC EDGAR XBRL facts. Don't trust us — verify.
| Figure | Value (as filed) | Filing | Source |
|---|---|---|---|
| Total revenueRevenues | $65.2B | 10-K · 2026-02-12 | View filing ↗ |
| Interest-bearing debtLong term debt | $29.5B | 10-K · 2025-02-19 | View filing ↗ |
| Cash & interest-bearing securities· 2 components | $7.4B | 10-K · 2026-02-12 | View filing ↗ |
| Cash and cash equivalents at carrying value | $7.3B | ||
| Short term investments | $154.8M | ||
| Interest incomeInvestment income interest | $175.2M | 10-K · 2025-02-19 | View filing ↗ |
| Total assetsAssets | $112.5B | 10-K · 2026-02-12 | View filing ↗ |
| ReceivablesAccounts receivable net current | $17.8B | 10-K · 2026-02-12 | View filing ↗ |
| Shares outstandingEntity common stock shares outstanding | 941.7M shares | 10-Q · 2026-04-30 | View filing ↗ |
| Priceyahoo:24mo-trailing-avg | $921.881 | — | market |
Values & Controversies
Separate from the shariah verdict above — always.
No flags. This company isn't on the BNC (Boycott National Committee) priority or divestment lists, or any grassroots BDS-supported campaign we track.